Immunological memory to SARS-CoV-2 assessed for up to eight months after infection
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Understanding immune memory to SARS-CoV-2 is critical for improving diagnostics and vaccines, and for assessing the likely future course of the COVID-19 pandemic. We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 254 samples from 188 COVID-19 cases, including 43 samples at ≥ 6 months post-infection. IgG to the Spike protein was relatively stable over 6+ months. Spike-specific memory B cells were more abundant at 6 months than at 1 month post symptom onset. SARS-CoV-2-specific CD4 + T cells and CD8 + T cells declined with a half-life of 3-5 months. By studying antibody, memory B cell, CD4 + T cell, and CD8 + T cell memory to SARS-CoV-2 in an integrated manner, we observed that each component of SARS-CoV-2 immune memory exhibited distinct kinetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
SARS-CoV-2 vaccines in development
Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098 · cited 3×
“Immunization studies in non-human primates have indicated that circulating neutralization titers of ~200 may provide sterilizing immunity against a relatively high dose URT challenge (66), and neutralizing titers of ~3,400 may provide sterilizing immunity against a very high dose URT challenge (67), although direct co…”
Self-citationRydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
Self-citationDevelopment of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
A dynamic COVID-19 immune signature includes associations with poor prognosis
Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., et al. (2020) · Science · doi:10.1126/science.abc4776 · Cited by 816
Origin and differentiation of human memory CD8 T cells after vaccination
Akondy, R. S., Fitch, M., Edupuganti, S., Yang, S., Kissick, H. T., Li, K. W., Youngblood, B. A., Abdelsamed, H. A., McGuire, D. J., Cohen, K. W., et al. (2017) · Nature · doi:10.1038/nature24633 · Cited by 517
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Baum, A., Ajithdoss, D., Copin, R., Zhou, A., Lanza, K., Negron, N., Ni, M., Wei, Y., Mohammadi, K., Musser, B., et al. (2020) · Science · doi:10.1126/science.abe2402 · Cited by 517
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
Zuo, J., Dowell, A. C., Pearce, H., Verma, K., Long, H. M., Begum, J., Aiano, F., Amin-Chowdhury, Z., Hoschler, K., Brooks, T., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00902-8 · Cited by 392
Lessons for COVID-19 immunity from other coronavirus infections
Sariol, A., & Perlman, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.005 · Cited by 317
Research works printed but not linked: 71
- 10.1001/jama.2020.16656 · DOI · Paper page
- 2020, Rapid generation of neutralizing antibody responses in COVID-19 patients, Cell Reports Medicine, 1, 100040, 10.1016/j.xcrm.2020.100040 · DOI · Paper page
- 10.1016/j.immuni.2020.07.026 · DOI · Paper page
- 2020, Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19, Nat Med, 26, 842, 10.1038/s41591-020-0901-9 · DOI · Paper page
- 10.1016/j.cell.2020.04.026 · DOI · Paper page
- P. S. Arunachalam , F. Wimmers , C. K. P. Mok , R. A. P. M. Perera , M. Scott , T. Hagan , N. Sigal , Y. Feng , L. Bristow , O. T.-Y. Tsang , D. Wagh , J. Coller , K. L. Pellegrini , D. Kazmin , G. Alaaeddine , W. S. Leung , J. M. C. Chan , T. S. H. Chik , C. Y. C. Choi , C. Huerta , M. P. McCullough , H. Lv , E. Anderson , S. Edupuganti , A. A. Upadhyay , S. E. Bosinger , H. T. Maecker , P. Khatri , N. Rouphael , M. Peiris , B. Pulendran , Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science, eabc6261 (2020). · DOI · Paper page
- 10.1126/science.abd4585 · DOI · Paper page
- Q. Zhang , P. Bastard , Z. Liu , J. L. Pen , M. Moncada-Velez , J. Chen , M. Ogishi , I. K. D. Sabli , S. Hodeib , C. Korol , J. Rosain , K. Bilguvar , J. Ye , A. Bolze , B. Bigio , R. Yang , A. A. Arias , Q. Zhou , Y. Zhang , F. Onodi , S. Korniotis , L. Karpf , Q. Philippot , M. Chbihi , L. Bonnet-Madin , K. Dorgham , N. Smith , W. M. Schneider , B. S. Razooky , H.-H. Hoffmann , E. Michailidis , L. Moens , J. E. Han , L. Lorenzo , L. Bizien , P. Meade , A.-L. Neehus , A. C. Ugurbil , A. Corneau , G. Kerner , P. Zhang , F. Rapaport , Y. Seeleuthner , J. Manry , C. Masson , Y. Schmitt , A. Schlüter , T. L. Voyer , T. Khan , J. Li , J. Fellay , L. Roussel , M. Shahrooei , M. F. Alosaimi , D. Mansouri , H. Al-Saud , F. Al-Mulla , F. Almourfi , S. Z. Al-Muhsen , F. Alsohime , S. A. Turki , R. Hasanato , D. van de Beek , A. Biondi , L. R. Bettini , M. D’Angio , P. Bonfanti , L. Imberti , A. Sottini , S. Paghera , E. Quiros-Roldan , C. Rossi , A. J. Oler , M. F. Tompkins , C. Alba , I. Vandernoot , J.-C. Goffard , G. Smits , I. Migeotte , F. Haerynck , P. Soler-Palacin , A. Martin-Nalda , R. Colobran , P.-E. Morange , S. Keles , F. Çölkesen , T. Ozcelik , K. K. Yasar , S. Senoglu , Ş. N. Karabela , C. R. Gallego , G. Novelli , S. Hraiech , Y. Tandjaoui-Lambiotte , X. Duval , C. Laouénan , C.-S. Clinicians§ , C. Clinicians§ , I. C. Group§ , F. C. C. S. Group§ , C.-C. Cohort§ , A. U. Covid-19, Biobank§, C. H. G. Effort§, NIAID-USUHS, T. C. I. Group§, A. L. Snow , C. L. Dalgard , J. Milner , D. C. Vinh , T. H. Mogensen , N. Marr , A. N. Spaan , B. Boisson , S. Boisson-Dupuis , J. Bustamante , A. Puel , M. Ciancanelli , I. Meyts , T. Maniatis , V. Soumelis , A. Amara , M. Nussenzweig , A. García-Sastre , F. Krammer , A. Pujol , D. Duffy , R. Lifton , S.-Y. Zhang , G. Gorochov , V. Béziat , E. Jouanguy , V. Sancho-Shimizu , C. M. Rice , L. Abel , L. D. Notarangelo , A. Cobat , H. C. Su , J.-L. Casanova , Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science, eabd4570 (2020). · DOI · Paper page
- 2020, An inflammatory cytokine signature predicts COVID-19 severity and survival, Nat Med, 26, 1636, 10.1038/s41591-020-1051-9 · DOI · Paper page
- 10.1126/sciimmunol.abd7114 · DOI · Paper page
- 10.1172/jci.insight.138070 · DOI · Paper page
- 10.1084/jem.20201012 · DOI · Paper page
- 2020, Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study, Lancet Microbe, 1, e290, 10.1016/S2666-5247(20)30144-0 · DOI · Paper page
- 10.1016/j.cell.2020.10.005 · DOI · Paper page
- N. Baumgarth , J. Nikolich-Žugich , F. E.-H. Lee , D. Bhattacharya , Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns. J Immunol, ji2000839 (2020). · DOI · Paper page
- 10.1101/2020.07.14.20151126 · doi:10.1101/2020.07.14.20151126
- 2020, SARS-CoV-2: A New Song Recalls an Old Melody, Cell Host Microbe, 27, 692, 10.1016/j.chom.2020.04.019 · DOI
- W. Deng , L. Bao , J. Liu , C. Xiao , J. Liu , J. Xue , Q. Lv , F. Qi , H. Gao , P. Yu , Y. Xu , Y. Qu , F. Li , Z. Xiang , H. Yu , S. Gong , M. Liu , G. Wang , S. Wang , Z. Song , Y. Liu , W. Zhao , Y. Han , L. Zhao , X. Liu , Q. Wei , C. Qin , Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science, eabc5343 (2020). · DOI · Paper page
- 2020, Potently neutralizing and protective human antibodies against SARS-CoV-2, Nature, 584, 443, 10.1038/s41586-020-2548-6 · DOI · Paper page
- 10.1126/science.abc7520 · DOI · Paper page
- 10.1101/2020.08.02.233320 · DOI
- 10.1126/sciimmunol.abd6160 · DOI · Paper page
- 2007, A review of the long-term protection after hepatitis A and B vaccination, Travel Med Infect Di, 5, 79, 10.1016/j.tmaid.2006.04.004 · DOI
- 10.1002/eji.201041187 · DOI · Paper page
- 10.1016/S0140-6736(20)30566-3 · DOI · Paper page
- 10.1073/pnas.1704507114 · DOI · Paper page
- S. Plotkin , W. Orenstein , P. Offit , Plotkin’s vaccines, 7th edition (Elsevier, 2018), Elsevier.
- 10.1016/j.immuni.2010.10.008 · DOI · Paper page
- 10.1016/j.smim.2004.02.008 · DOI · Paper page
- 10.1146/annurev-immunol-041015-055531 · DOI · Paper page
- 10.1126/science.abb5793 · DOI · Paper page
- C. M. Saad-Roy , C. E. Wagner , R. E. Baker , S. E. Morris , J. Farrar , A. L. Graham , S. A. Levin , M. J. Mina , C. J. E. Metcalf , B. T. Grenfell , Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years. Science, eabd7343 (2020). · DOI · Paper page
- 2020, Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, Nat Med, 26, 1200, 10.1038/s41591-020-0965-6 · DOI · Paper page
- 2020, Humoral Immune Response to SARS-CoV-2 in Iceland, New Engl J Med, 383, 1724, 10.1056/NEJMoa2026116 · DOI · Paper page
- 10.1126/science.abd7728 · DOI · Paper page
- 2020, Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology, Cell, 183, 1024, 10.1016/j.cell.2020.09.037 · DOI · Paper page
- 2020, Convergent antibody responses to SARS-CoV-2 in convalescent individuals, Nature, 584, 437, 10.1038/s41586-020-2456-9 · DOI · Paper page
- 10.1126/science.abc6284 · DOI · Paper page
- 10.1126/sciimmunol.abe5511 · DOI · Paper page
- 10.1016/j.cell.2020.11.029 · DOI · Paper page
- 2019, Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection, Cell, 177, 1566, 10.1016/j.cell.2019.04.036 · DOI · Paper page
- 10.1073/pnas.1921388117 · DOI · Paper page
- 10.1128/JVI.02632-06 · DOI · Paper page
- J. Neidleman , X. Luo , J. Frouard , G. Xie , G. Gill , E. S. Stein , M. McGregor , T. Ma , A. F. George , A. Kosters , W. C. Greene , J. Vasquez , E. Ghosn , S. Lee , N. R. Roan , SARS-CoV-2-specific T cells exhibit phenotypic features of robust helper function, lack of terminal differentiation, and high proliferative potential. Cell Reports Medicine, 100081 (2020). · doi:10.1101/2020.06.08.138826
- 10.1038/nm.3350 · DOI · Paper page
- 10.1016/j.immuni.2019.04.011 · DOI · Paper page
- J. A. Juno , H.-X. Tan , W. S. Lee , A. Reynaldi , H. G. Kelly , K. Wragg , R. Esterbauer , H. E. Kent , C. J. Batten , F. L. Mordant , N. A. Gherardin , P. Pymm , M. H. Dietrich , N. E. Scott , W.-H. Tham , D. I. Godfrey , K. Subbarao , M. P. Davenport , S. J. Kent , A. K. Wheatley , Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med, 1–7 (2020). · DOI · Paper page
- 10.1101/2020.10.15.341958 · DOI
- 10.1101/2020.11.03.367391 · DOI
- 10.4049/jimmunol.171.10.4969 · DOI · Paper page
- 10.1038/nature07231 · DOI · Paper page
- 10.1101/2020.11.01.362319 · DOI
- 10.1038/nm917 · DOI · Paper page
- 10.1038/s41586-020-2550-z · DOI · Paper page
- 2020, Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques, Nature, 586, 583, 10.1038/s41586-020-2607-z · DOI · Paper page
- 2020, Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates, New Engl J Med, 383, 1544, 10.1056/NEJMoa2024671 · DOI · Paper page
- 10.1126/science.abc5312 · DOI · Paper page
- 10.1016/j.immuni.2016.05.006 · DOI · Paper page
- 10.1084/jem.20110740 · DOI · Paper page
- 10.1146/annurev-immunol-042617-053214 · DOI · Paper page
- 10.1016/S0140-6736(98)02364-2 · DOI · Paper page
- 10.1086/589862 · DOI · Paper page
- 10.1101/cshperspect.a029454 · DOI · Paper page
- 10.1038/s41586-020-2608-y · DOI · Paper page
- 10.1016/s1473-3099(20)30764-7 · DOI · Paper page
- 10.1093/cid/ciaa1275 · DOI · Paper page
- 10.1101/2020.11.02.20222778 · DOI · Paper page
- 10.1101/2020.11.18.20234369 · DOI
- 10.1126/science.abb2507 · DOI · Paper page
- 2020, A serological assay to detect SARS-CoV-2 seroconversion in humans, Nat Med, 26, 1033, 10.1038/s41591-020-0913-5 · DOI · Paper page
- 10.1016/0022-1759(95)00289-8 · DOI
Cited by
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Bubar, K. M., Reinholt, K., Kissler, S. M., Lipsitch, M., Cobey, S., Grad, Y. H., & Larremore, D. B. (2021) · Science · doi:10.1126/science.abe6959 · Cited by 775
Ella, R., Reddy, S., Jogdand, H., Sarangi, V., Ganneru, B., Prasad, S., Das, D., Raju, D., Praturi, U., Sapkal, G., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00070-0 · Cited by 378
Saadat, S., Rikhtegaran Tehrani, Z., Logue, J., Newman, M., Frieman, M. B., Harris, A. D., & Sajadi, M. M. (2021) · JAMA · doi:10.1001/jama.2021.3341 · Cited by 364
Hartley, G. E., Edwards, E. S. J., Aui, P. M., Varese, N., Stojanovic, S., McMahon, J., Peleg, A. Y., Boo, I., Drummer, H. E., Hogarth, P. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abf8891 · Cited by 296
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
Bettini, E., & Locci, M. (2021) · Vaccines · doi:10.3390/vaccines9020147 · Cited by 279
Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
Mascellino, M. T., Di Timoteo, F., De Angelis, M., & Oliva, A. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s315727 · Cited by 253
Lineburg, K. E., Grant, E. J., Swaminathan, S., Chatzileontiadou, D. S. M., Szeto, C., Sloane, H., Panikkar, A., Raju, J., Crooks, P., Rehan, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.006 · Cited by 183
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses
Agerer, B., Koblischke, M., Gudipati, V., Montaño-Gutierrez, L. F., Smyth, M., Popa, A., Genger, J.-W., Endler, L., Florian, D. M., Mühlgrabner, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg6461 · Cited by 172
“CTL responses have been described in great detail in SARS-CoV-2–infected patients ( 3 , 4 , 11 – 15 ).”
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong
Mok, C. K. P., Cohen, C. A., Cheng, S. M. S., Chen, C., Kwok, K., Yiu, K., Chan, T., Bull, M., Ling, K. C., Dai, Z., et al. (2022) · Respirology · doi:10.1111/resp.14191 · Cited by 162
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L. R., Chen, D.-Y., Gallagher, K. M. E., Bauer, M. R., Taylor, H. B., Dunn, W. A., Tarr, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.046 · Cited by 147
Self-citationPersistent cellular immunity to SARS-CoV-2 infection
Breton, G., Mendoza, P., Hägglöf, T., Oliveira, T. Y., Schaefer-Babajew, D., Gaebler, C., Turroja, M., Hurley, A., Caskey, M., & Nussenzweig, M. C. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202515 · Cited by 129
Perez-Saez, J., Zaballa, M.-E., Yerly, S., Andrey, D. O., Meyer, B., Eckerle, I., Balavoine, J.-F., Chappuis, F., Pittet, D., Trono, D., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.06.040 · Cited by 46
Metadata
- Authors
- Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., Nakao, C., Rayaprolu, V., Rawlings, S. A., Peters, B., Krammer, F., Simon, V., Saphire, E. O., Smith, D. M., Weiskopf, D., Sette, A., & Crotty, S.
- Venue
- bioRxiv (Cold Spring Harbor Laboratory)
- Publisher
- openRxiv
- Published
- 2020-11-16
- OpenAlex
- W3099064899
- Cited by
- 128
- References
- 11
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.